Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05134311 · ClinicalTrials.gov registry record · NA
Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies
A NA study, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT05134311 is a NA study that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 270 participants.
The verdict
NCT05134311, a NA study, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
The ability to have a visual aid to depict areas of vascular disease that are affecting the patient's health can help in patient comprehension of the problem. This comprehension can lead to better understanding of the issue and increase patient compliance to treatment. The hand drawn sketch produced by the ultrasound technologist provides an inadequate visualization of the vascular insufficiency that is causing the patient's symptoms. PIUR imaging has developed PIUR Infinity tUS, a 3D freehand tomographic ultrasound system capable of rapid, safe and accurate reconstructive 3D quantifiable vascular imaging. This system will provide a low cost and reproducible imaging solution that will be an effective educational tool for people with vascular disease.
Interventions
- DEVICE PIUR tUS Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05134311
The ClinicalTrials.gov registry entry for NCT05134311 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PIUR tUS Imaging System is the first listed.
NCT05134311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05134311 about?
NCT05134311 is a clinical study titled "Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies". The ability to have a visual aid to depict areas of vascular disease that are affecting the patient's health can help in patient comprehension of the problem. This comprehension can lead to better understanding of the issue and increase patient compliance to treatment. The hand drawn sketch produced...
What is the current status of trial NCT05134311?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2025-07-01. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT05134311?
The interventions under investigation include: PIUR tUS Imaging System (DEVICE).
Who is sponsoring clinical trial NCT05134311?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.